SF
IDXX icon

Summit Financial’s Idexx Laboratories IDXX Stock Holding History

Summit Financial’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$709K Sell
1,346
-118
-8% -$66.2K 0.01% 968
2026
Q1 		$823K Buy
1,464
+192
+15% +$123K 0.01% 840
2025
Q4 		$861K Sell
1,272
-319
-20% -$217K 0.01% 714
2025
Q3 		$1.02M Sell
1,591
-163
-9% -$98.9K 0.02% 653
2025
Q2 		$941K Sell
1,754
-57
-3% -$27.3K 0.02% 424
2025
Q1 		$761K Sell
1,811
-611
-25% -$265K 0.02% 424
2024
Q4 		$1M Sell
2,422
-110
-4% -$48.2K 0.04% 316
2024
Q3 		$1.28M Buy
2,532
+1,198
+90% +$582K 0.05% 225
2024
Q2 		$650K Buy
+1,334
New +$670K 0.03% 287

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Summit Financial's IDXX Position: Q2 2026 in Review

Summit Financial reduced its Idexx Laboratories (IDXX) stake by 8.1% in Q2 2026, selling an estimated $66.2K and leaving 1,346 shares worth $709K. The position accounts for 0.01% of the portfolio, ranked #968.

Summit Financial first reported a position in IDXX in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.28M in Q3 2024. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Summit Financial held 1,346 shares of Idexx Laboratories worth $709K as of Q2 2026.
  • Summit Financial sold 118 Idexx Laboratories shares in Q2 2026, an estimated $66.2K.
  • Idexx Laboratories made up 0.01% of Summit Financial's portfolio in Q2 2026, its #968 holding.
  • Summit Financial first reported a position in Idexx Laboratories in Q2 2024 and has held it in 9 quarters since.
  • Summit Financial's Idexx Laboratories position peaked at $1.28M in Q3 2024.
  • 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Summit Financial's 13F filing for Q2 2026, filed 12 Aug 2026.